Veeva’s AI Opportunity Expands, but Early Commercialization Risks Support a Hold; $275 Price Target Unchanged
at www.tipranks.com (Fri, 6-Nov 9:32 AM)
IQVIA Expands Veeva Partnership by Standardizing CTMS, eTMF, Study Startup, and Site Connect Across Clinical Development Studies
Market Chameleon (Tue, 13-Oct 8:19 AM)
